ABSSI - check how many more products came to market, yes B is single dose but market has multiple options
Ovarian cancer - no one knows if K even works, if you search there are many products in P3 or near approval but K is too far behind to wven consider it as an possibility
Psoriasis - look at recent results from some key products, not sure P will even match those numbers
OM - that is one area where we can see impact if they prove same results in larger trial